June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Combination of oral progesterone and lipoic acid treatment and its effect on oxidative stress in an animal model of retinal degeneration
Author Affiliations & Notes
  • Maria Miranda
    Physiology, Univ CEU-Cardenal Herrera, Moncada, Valencia, Spain
  • Ramírez-Lamelas Tanya Dolores
    Physiology, Univ CEU-Cardenal Herrera, Moncada, Valencia, Spain
  • Rosa López-Pedrajas
    Physiology, Univ CEU-Cardenal Herrera, Moncada, Valencia, Spain
  • Roberto Gimeno-Hernández
    Physiology, Univ CEU-Cardenal Herrera, Moncada, Valencia, Spain
  • Ángel Fernández-Carbonell
    Physiology, Univ CEU-Cardenal Herrera, Moncada, Valencia, Spain
  • Inmaculada Almansa
    Physiology, Univ CEU-Cardenal Herrera, Moncada, Valencia, Spain
  • Javier Araiz
    ICQO, Bilbao, Spain
    Universidad del País Vasco, Leioa, Spain
  • Footnotes
    Commercial Relationships   Maria Miranda, None; Ramírez-Lamelas Dolores , None; Rosa López-Pedrajas, None; Roberto Gimeno-Hernández, None; Ángel Fernández-Carbonell, None; Inmaculada Almansa, None; Javier Araiz, None
  • Footnotes
    Support  This work was supported by grants from Proyecto Precompetitivo Banco Santander UCHCEU
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5353. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maria Miranda, Ramírez-Lamelas Tanya Dolores, Rosa López-Pedrajas, Roberto Gimeno-Hernández, Ángel Fernández-Carbonell, Inmaculada Almansa, Javier Araiz; Combination of oral progesterone and lipoic acid treatment and its effect on oxidative stress in an animal model of retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5353.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We have previously shown the beneficial effects of progesterone (P4) on the evolution of cell death in two animal models of retinitis pigmentosa (RP), the rd1 and the rd10 mice. RP is a complex disease that affects photoreceptors and that have been related to oxidative stress. Indeed, the possible P4 action mechanism may be related to its ability to regulate thiol metabolism and to decrease lipid peroxidation. In an attempt to improve the positive effects of P4, the aim of this study was to combine P4 treatment with a well known and potent antioxidant (lipoic acid (LA)) and to establish the changes induced by this combined treatment in the retina of rd1 mice.

Methods : LA (100mg/kg), P4 (100mg/Kg) and a combination of both (LA+P4), were administered orally to rd1 mice at different postnatal (PN) days. On PN11, eyes were enucleated and sectioned (N=6). Histological evaluation was performed using in situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay. Glial fibrillary acidic protein (GFAP) and glutamate cisteyne ligase (GCL) retinal immunohistochemistry were also performed. Additionally, we measured the total antioxidant capacity of LA and P4 and three of their related metabolites (dihydrolipic acid (DHLA), allopregnenolone and estradiol). SPSS software package version 16.0 was used, and the level of significance was set at p<0.05, one-way ANOVA with the corresponding post hoc test was performed.

Results : The combination of P4 and LA administration improved cell survival and showed better photoreceptor protection effect than when administered alone, as shown by the decrease in the number of TUNEL positive cells. In addition, AL, P4 and their combination oral treatment are able to prevent the characteristic gliosis observed in the retina of the rd1 mouse model (74,74% of reduction at the peripheral retina) and a slight decrease of GCLC expression (37,20% of reduction at the peripheral retina) was observed in the retina of rd1 mice treated with the combination of LA and P4 with respect to mice treated only with LA or P4. LA and P4 metabolites have shown higher total antioxidant capacity.

Conclusions : LA and P4 may have neuroprotective actions in the retina and probably their action mechanism is due to their metabolization in the eye.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×